These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38704497)

  • 21. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
    Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
    J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the Impact of PrEP Programs for Adolescent Sexual Minority Males Based on Empirical Estimates for the PrEP Continuum of Care.
    Hamilton DT; Rosenberg ES; Sullivan PS; Wang LY; Dunville RL; Barrios LC; Aslam M; Mustanski B; Goodreau SM
    J Adolesc Health; 2021 Mar; 68(3):488-496. PubMed ID: 32798099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PrEP Use and Persistence Among Young Sexual Minority Men 17-24 Years Old During the COVID-19 Pandemic.
    Hong C; Horvath KJ; Stephenson R; Nelson KM; Petroll AE; Walsh JL; John SA
    AIDS Behav; 2022 Mar; 26(3):631-638. PubMed ID: 34387777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Awareness and Acceptability of Undetectable = Untransmittable Among a U.S. National Sample of HIV-Negative Sexual and Gender Minorities.
    Carneiro PB; Westmoreland DA; Patel VV; Grov C
    AIDS Behav; 2021 Feb; 25(2):634-644. PubMed ID: 32897485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.
    Grant RM; Anderson PL; McMahan V; Liu A; Amico KR; Mehrotra M; Hosek S; Mosquera C; Casapia M; Montoya O; Buchbinder S; Veloso VG; Mayer K; Chariyalertsak S; Bekker LG; Kallas EG; Schechter M; Guanira J; Bushman L; Burns DN; Rooney JF; Glidden DV;
    Lancet Infect Dis; 2014 Sep; 14(9):820-9. PubMed ID: 25065857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beliefs About the End of AIDS, Concerns About PrEP Functionality, and Perceptions of HIV Risk as Drivers of PrEP Use in Urban Sexual Minority Men: The P18 Cohort Study.
    Halkitis PN; Jaiswal J; Griffin-Tomas M; Krause KD; D'Avanzo P; Kapadia F
    AIDS Behav; 2018 Nov; 22(11):3705-3717. PubMed ID: 29971731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PrEP Uptake and Discontinuation Among a U.S. National Sample of Transgender Men and Women.
    Zarwell M; John SA; Westmoreland D; Mirzayi C; Pantalone DW; Golub S; Nash D; Grov C
    AIDS Behav; 2021 Apr; 25(4):1063-1071. PubMed ID: 33057893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "This Is To Help Me Move Forward": The Role of PrEp in Harnessing Sex Positivity and Empowerment Among Black Sexual Minority Men in the Southern United States.
    Simon KA; Hanna-Walker V; Clark AN; Driver R; Kalinowski J; Watson RJ; Eaton LA
    J Sex Res; 2023; 60(5):741-751. PubMed ID: 36239604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Awareness and Knowledge of Pre-exposure Prophylaxis Among Sexual and Gender Minority Adolescents Assigned Male at Birth in the United States.
    Matson M; Nery-Hurwit M; Crosby S; Greene GJ; Macapagal K
    Arch Sex Behav; 2021 May; 50(4):1701-1711. PubMed ID: 33982212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.
    Sun CJ; Anderson KM; Bangsberg D; Toevs K; Morrison D; Wells C; Clark P; Nicolaidis C
    J Gen Intern Med; 2019 Apr; 34(4):535-543. PubMed ID: 30719647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parental Concerns of Their Sexual and Gender Minority Adolescents Using HIV Pre-Exposure Prophylaxis.
    Owens C; Brandenburg D; Grant MJ; Carter K; Hoffman M; Hubach RD
    AIDS Educ Prev; 2023 Feb; 35(1):85-99. PubMed ID: 36735230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The new MTV generation: Using methamphetamine, Truvada™, and Viagra™ to enhance sex and stay safe.
    Hammoud MA; Vaccher S; Jin F; Bourne A; Haire B; Maher L; Lea T; Prestage G
    Int J Drug Policy; 2018 May; 55():197-204. PubMed ID: 29526546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breaking Inertia: Movement Along the PrEP Cascade in a Longitudinal US National Cohort of Sexual Minority Individuals at Risk for HIV.
    Mehrotra ML; Westmoreland DA; Patel VV; Hojilla JC; Grov C;
    J Acquir Immune Defic Syndr; 2021 Apr; 86(5):e118-e125. PubMed ID: 33661823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Readiness to Provide Oral and Injectable PrEP for Sexual and Gender Minority Youth Among Healthcare Providers and Clinics in the U.S. Northeast.
    Valente PK; Rusley JC; Operario D; Biello KB
    J Adolesc Health; 2023 May; 72(5):722-729. PubMed ID: 36604205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sexual Risk Profiles Among Black Sexual Minority Men: Implications for Targeted PrEP Messaging.
    Dangerfield DT; Kuo I; Magnus M; Beauchamp G; Fields SD; Nelson L; Shoptaw S; Wilton L; Wheeler DP
    Arch Sex Behav; 2021 Oct; 50(7):2947-2954. PubMed ID: 34590218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of PrEP Uptake Among Young Sexual Minority Men and Transgender Women in New York City: The Need to Reframe "Risk" Messaging and Normalize Preventative Health.
    Jaiswal J; LoSchiavo C; Meanley S; Hascher K; Cox AB; Dunlap KB; Singer SN; Halkitis PN
    AIDS Behav; 2021 Oct; 25(10):3057-3073. PubMed ID: 33830327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'I make sure my doctor doesn't know that I use meth': perceived barriers to pre-exposure prophylaxis (PrEP) uptake among community peer educators in Seattle (WA, USA).
    McMahan VM; Violette LR; Andrasik MP; Martin A; Garske L; Stekler JD
    Sex Health; 2020 Feb; 17(1):29-37. PubMed ID: 31954432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unsupervised Machine Learning to Detect and Characterize Barriers to Pre-exposure Prophylaxis Therapy: Multiplatform Social Media Study.
    Xu Q; Nali MC; McMann T; Godinez H; Li J; He Y; Cai M; Lee C; Merenda C; Araojo R; Mackey TK
    JMIR Infodemiology; 2022; 2(1):e35446. PubMed ID: 37113799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the impact of COVID-19: A cohort comparison study of drug use and risky sexual behavior among sexual minority men in the U.S.A.
    Starks TJ; Jones SS; Sauermilch D; Benedict M; Adebayo T; Cain D; Simpson KN
    Drug Alcohol Depend; 2020 Nov; 216():108260. PubMed ID: 32890975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among Young Adult Sexual Minority Men and Transgender Women.
    Weeden T; Garofalo R; Johnson AK; Schnall R; Cervantes M; Scherr T; Kuhns LM
    Acad Pediatr; 2024; 24(7):1110-1115. PubMed ID: 38631476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.